Document is current
Any future updates will be listed below
-
Authors
Takahashi, Naoki
Hara, Hiroki
Nagashima, Kengo
Hirata, Kenro
Masuishi, Toshiki
Matsumoto, Toshihiko
Kawakami, Hisato
Yamazaki, Kentaro
Hironaka, Shuichi
Boku, Narikazu
Muro, Kei
- License Information
-
More Information
Article History
Received: 9 April 2023
Accepted: 20 July 2023
First Online: 5 August 2023
Declarations
:
: This study was approved by the Certified Review Board of Shizuoka Cancer Center (CRB4180010), and permission to conduct the study was obtained from the management of all participating facilities. Written informed consent is obtained from all participants.
: Not applicable.
: NT has received honoraria from Taiho. HH has received honoraria form Eli Lilly and Taiho, and research grant from Taiho. KN has received a consulting fee (paid to the university) from Eli Lilly. KH has received research grant from Taiho. TM (Toshiki Masuishi) have no conflicts of interest to declare. TM (Toshihiko Matsumoto) has received honoraria from Eli Lilly and Taiho. HK has received consulting fees from Eli Lilly and Taiho, and research funding from Taiho. KY has received research grant from Taiho, and received honoraria from Taiho and Eli Lilly. SH has received honoraria from Eli Lilly and Taiho. NB has received honoraria from Eli Lilly and Taiho. KM has received research grant from Taiho, and received honoraria from Taiho and Eli Lilly.
